Ashish Verma
@ashunephro.bsky.social
300 followers 260 following 11 posts
Clinician Scientist at Boston University Chobanian & Avedisian School of Medicine. Nephrologist at Boston Medical Center and BU Amyloidosis center https://profiles.bu.edu/Ashish.Verma
Posts Media Videos Starter Packs
Reposted by Ashish Verma
asnpublications.bsky.social
Foot Process Effacement (FPE) could serve as a valuable marker for assessing the risk of disease progression across various kidney pathologies. Read more in #ASNKidney360: kidney.pub/KID0894

@ashunephro.bsky.social @sophieclaudel.bsky.social
Reposted by Ashish Verma
asnpublications.bsky.social
Despite repeating proteinuria measurements throughout a patient with CKD's clinical course, clinicians may overlook important temporal patterns that emerge. Read more about proteinuria trajectories and risk of adverse clinical outcomes: kidney.pub/KID0849 #ASNKidney360 @ashunephro.bsky.social
Reposted by Ashish Verma
f2harrell.bsky.social
Milestone release of #rstats rms package is now on CRAN with a full suite of survival analysis fitting, validation, and graphical display functions based on semiparametric models, generalizing the Cox PH model to a spectrum of models including accelerated failure time. hbiostat.org/r/rms #StatsSky
RMS
hbiostat.org
ashunephro.bsky.social
Excited to share our comprehensive review “Cardiovascular-Kidney-Metabolic Health: Definition, Staging, Risk Assessment, and Therapeutic Considerations” #CardiologyClinics @sophieclaudel.bsky.social @ahascience.bsky.social
@asnkidney.bsky.social
kwnsfk27.r.eu-west-1.awstrack.me/L0/https:%2F...
Reposted by Ashish Verma
Reposted by Ashish Verma
asnpublications.bsky.social
Cardiovascular–kidney–metabolic (CKM) syndrome stages 1 to 4 are associated with a graded risk of cardiovascular mortality in a nationally representative sample of U.S. adults. https://bit.ly/JASN0637
#ASNJASN
@ashunephro.bsky.social
@sophieclaudel.bsky.social
Reposted by Ashish Verma
asnpublications.bsky.social
Cumulative Incidence of Mortality (CKM) syndrome stages 1 to 4 are associated with a graded risk of cardiovascular mortality in a nationally representative sample of U.S. adults. https://bit.ly/JASN0637
#ASNJASN
@ashunephro.bsky.social
@sophieclaudel.bsky.social
Reposted by Ashish Verma
sophieclaudel.bsky.social
Learned quite a lot about interactions, thresholds, and synergistic effects from @ashunephro.bsky.social in this analysis of albuminuria, heart failure, and CKD progression. Our findings emphasize albuminuria as a key biomarker for CKM health. 🫘
@jaccjournals.bsky.social #NephSky
ashunephro.bsky.social
Delighted to share our study published in @jaccjournals.bsky.social led by @sophieclaudel.bsky.social. We demonstrated deleterious synergy between albuminuria and heart failure as risk factors for CKD progression.
www.jacc.org/doi/10.1016/...
ashunephro.bsky.social
Delighted to share our study published in @jaccjournals.bsky.social led by @sophieclaudel.bsky.social. We demonstrated deleterious synergy between albuminuria and heart failure as risk factors for CKD progression.
www.jacc.org/doi/10.1016/...
Reposted by Ashish Verma
edgarvlermamd.bsky.social
Albuminuria in Cardiovascular, Kidney, and Metabolic Disorders: A State-of-the-Art Review ca. 2025
#Nephpearls #NephSky

👉🏼 pubmed.ncbi.nlm.nih.gov/40063723/
Reposted by Ashish Verma
chillslincoln79.bsky.social
Albuminuria in Cardiovascular, Kidney, and Metabolic Disorders: A State-of-the-Art Review 👩‍🔬🥼🧪👨‍🔬 #CardioSky #NephSky #cardiovascular #cardio-renal #metabolicdisorder #KidneyResearch #kidneydisease 👇👇👇

www.ahajournals.org/doi/epub/10....
www.ahajournals.org
ashunephro.bsky.social
Please let me know your email id.
ashunephro.bsky.social
Send me your email id.
Reposted by Ashish Verma
sophieclaudel.bsky.social
Extremely grateful to @ahascience.bsky.social and @ashunephro.bsky.social for the opportunity to publish this comprehensive review on albuminuria in #Circulation. We cover albuminuria in the spectrum of #CKM disorders. Please take a look!
@nephjc.bsky.social #NephSky
ashunephro.bsky.social
Thrilled to share our state of art review led by extraordinary @sophieclaudel.bsky.social
“Albuminuria in Cardiovascular, Kidney, and Metabolic Disorders: A State-of-the-Art Review"
www.ahajournals.org/eprint/SXXGK...

@ahascience.bsky.social
@ahajournals.bsky.social
@asnkidney.bsky.social
ashunephro.bsky.social
Thrilled to share our state of art review led by extraordinary @sophieclaudel.bsky.social
“Albuminuria in Cardiovascular, Kidney, and Metabolic Disorders: A State-of-the-Art Review"
www.ahajournals.org/eprint/SXXGK...

@ahascience.bsky.social
@ahajournals.bsky.social
@asnkidney.bsky.social
Reposted by Ashish Verma
sophieclaudel.bsky.social
Excited to share this research letter looking at albuminuria values in healthy adults! We followed IFCC guidelines for establishing references ranges, which had not previously been shown in the literature, and consider what “normal” should be by sex.
ashunephro.bsky.social
We sought to quantify the upper limit of normal for albuminuria among US adults by the IFCC standard. Our study led by @sophieclaudel.bsky.social “Albuminuria References Ranges in Healthy US Adults”

academic.oup.com/jalm/advance...
Albuminuria References Ranges in Healthy US Adults
To the Editor:
academic.oup.com
ashunephro.bsky.social
We sought to quantify the upper limit of normal for albuminuria among US adults by the IFCC standard. Our study led by @sophieclaudel.bsky.social “Albuminuria References Ranges in Healthy US Adults”

academic.oup.com/jalm/advance...
Albuminuria References Ranges in Healthy US Adults
To the Editor:
academic.oup.com
ashunephro.bsky.social
Adults with higher levels of albuminuria within the low range (UACR <30 mg/g) and no major cardiovascular risk factors have higher risks of cardiovascular and all-cause mortality. academic.oup.com/eurjpc/artic... @sophieclaudel.bsky.social